Polarization of Tumor Milieu: Therapeutic Implications

作者: Stanisław Szala , Magdalena Jarosz-Biej , Tomasz Cichoń , Ryszard Smolarczyk , Aleksander Sochanik

DOI: 10.1007/978-3-662-44946-2_22

关键词: Extracellular matrixMedicineTumor microenvironmentCpG siteAntigenAngiogenesisTransforming growth factorCancer cellEndoglinCancer research

摘要: During neoplastic progression, cancer cells recruit inflammatory (monocytes, neutrophils, mast, and dendritic cells, etc.), which become “educated” under the influence of factors released by (mainly cytokines). As a consequence, former lose their ability to present antigens. Instead, they involved in remodeling extracellular matrix stimulate formation blood vessels (angiogenesis). Proangiogenic act as immunosuppressants tumor milieu becomes proangiogenic immunosuppressive. Latest studies have demonstrated possibility reverting such proangiogenic/immunosuppressive microenvironment inhibits growth. Reverted anti-angiogenic immunostimulatory. Reversal is especially feasible with combinations immunomodulatory factors. For instance, VEGF, VEGFR2, or TGF-β activity inhibitors immunostimulants anticancer vaccines, CpG sequences, IL-12 were effective inhibiting growth experimental tumors. In our hands, DNA vaccine directed against endoglin (CD105), vascular endothelial cell-surface protein, when combined IL-12, led ca. 30 % cure rate mice bearing melanoma It appears that attempts therapeutically revert might merit further consideration.

参考文章(54)
Kazumi Ebata, Yukihiro Shimizu, Yasuhiro Nakayama, Masami Minemura, Jun Murakami, Tsutomu Kato, Satoshi Yasumura, Terumi Takahara, Toshiro Sugiyama, Shigeru Saito, Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. Journal of Immunology. ,vol. 176, pp. 4113- 4124 ,(2006) , 10.4049/JIMMUNOL.176.7.4113
Alberto Mantovani, Subhra K Biswas, Maria Rosaria Galdiero, Antonio Sica, Massimo Locati, Macrophage plasticity and polarization in tissue repair and remodelling The Journal of Pathology. ,vol. 229, pp. 176- 185 ,(2013) , 10.1002/PATH.4133
I Waldhauer, A Steinle, NK cells and cancer immunosurveillance. Oncogene. ,vol. 27, pp. 5932- 5943 ,(2008) , 10.1038/ONC.2008.267
Gourapura J Renukaradhya, Masood A Khan, Marcus Vieira, Wenjun Du, Jacquelyn Gervay-Hague, Randy R Brutkiewicz, Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma Blood. ,vol. 111, pp. 5637- 5645 ,(2008) , 10.1182/BLOOD-2007-05-092866
Melvyn T. Chow, Andreas Möller, Mark J. Smyth, Inflammation and immune surveillance in cancer. Seminars in Cancer Biology. ,vol. 22, pp. 23- 32 ,(2012) , 10.1016/J.SEMCANCER.2011.12.004
Douglas M. Noonan, Andrea De Lerma Barbaro, Nicola Vannini, Lorenzo Mortara, Adriana Albini, Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer and Metastasis Reviews. ,vol. 27, pp. 31- 40 ,(2008) , 10.1007/S10555-007-9108-5
Brian Ruffell, Nesrine I. Affara, Lisa M. Coussens, Differential macrophage programming in the tumor microenvironment. Trends in Immunology. ,vol. 33, pp. 119- 126 ,(2012) , 10.1016/J.IT.2011.12.001
Eric Tartour, H. Pere, B. Maillere, M. Terme, N. Merillon, J. Taieb, F. Sandoval, F. Quintin-Colonna, K. Lacerda, A. Karadimou, C. Badoual, A. Tedgui, W. H. Fridman, S. Oudard, Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy Cancer and Metastasis Reviews. ,vol. 30, pp. 83- 95 ,(2011) , 10.1007/S10555-011-9281-4
Magali Terme, Orianne Colussi, Elie Marcheteau, Corinne Tanchot, Eric Tartour, Julien Taieb, Modulation of immunity by antiangiogenic molecules in cancer. Clinical & Developmental Immunology. ,vol. 2012, pp. 492920- 492920 ,(2012) , 10.1155/2012/492920
Ge Ma, Johnny Kao, George X. Wang, Marcia Meseck, Max Sung, Myron Schwartz, Celia M. Divino, Ping-Ying Pan, Shu-Hsia Chen, Junko Ozao-Choy, The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Research. ,vol. 69, pp. 2514- 2522 ,(2009) , 10.1158/0008-5472.CAN-08-4709